Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03644186
Title To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH) (TOUCH)
Acronym TOUCH
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors International Breast Cancer Study Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA | FRA | CHE | BEL


No variant requirements are available.